Bioenergetic Effect of Pioglitazone in CLD-PH

Abroad (travel likely)RecruitingPHASE2

Conditions

Pulmonary Hypertension · Pulmonary Hypertension Due to Lung Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Emory Healthcare System, Atlanta, Georgia, United States

    Contact: Study coordinator (Jane Gillespie, RN) · jegille@emory.edu · 404-712-8204
    Contact: Principal Investigator (Aaron W Trammell, MD, MSc)
Study leads
  • Aaron Trammell

    Principal Investigator

    Emory University